Stephens Investment Management Group portfolio
Type not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Jul 29, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Stephens Investment Management Group reported a $9.3 bn portfolio of 176 positions to the SEC as of the end of Q2 2026. Its largest positions are RBC, FCFS, LGND. During the quarter it opened Twist Bioscience.
Sections with a free account
What it reported after the quarter end (Q2 2026)
The 13F shows the portfolio as of Jun 30, 2026. Since then Stephens Investment Management Group has filed these own trades with the SEC (Form 4, when it owns more than 10% of a company or holds a role in it) and stakes above 5% (13D and 13G). It is not everything it did: only what it must report before the next 13F.
Stake reported in the company · event of Jun 30, 2026 · filed Aug 7, 2026 · filing ↗
What changed this quarter
184 positions with a change (14 new, 135 added to, 24 trimmed, 11 sold). 5 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Encore Capital Group−80%fewer sharesReduced1.3% → 0.3%
- Vertiv Holdings−51%fewer sharesReduced1.7% → 0.9%
- Twist Bioscience+0.8 ppof portfolioNew— → 0.8%
- MACOM Technology Solutions Holdings−39%fewer sharesReduced1.6% → 1.3%
- Bloom Energy−44%fewer sharesReduced0.9% → 0.9%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- RBC BearingsRBC1.8%
- Firstcash HoldingsFCFS1.7%
- Ligand PharmaceuticalsLGND1.6%
- ExelixisEXEL1.6%
- Credo Technology Group HoldingCRDO1.5%
- Lattice SemiconductorLSCC1.4%
- RepligenRGEN1.4%
- IconICLR1.3%
- Astera LabsALAB1.3%
- MACOM Technology Solutions HoldingsMTSI1.3%
- BWX TechnologiesBWXT1.3%
- TechnipFMCFTI1.2%
- Burlington StoresBURL1.2%
- Live Nation EntertainmentLYV1.2%
- Halozyme TherapeuticsHALO1.2%
Portfolio by sector
- ● Information Technology 33%
- ● Industrials 20%
- ● Health Care 18%
- ● Consumer Discretionary 10%
- ● Financials 9%
- ● Energy 5%
- ● Communication Services 2%
- ● Consumer Staples 1%
- ● Materials 1%
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified: we have not assigned a type because we found no document that is enough to tell. Most 13F filers are in this situation: we only review in depth those that meet the portfolio criteria.
Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions; its top 10 positions are under 45%. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- Mirova USInvestment firm · $9.3 bn
- Edgewood ManagementInvestment firm · $9.7 bn
- Gardner Russo & QuinnInvestment firm · $8.9 bn
- Aspex Management (HK)Investment firm · $8.9 bn
- Egerton Capital (UK) LLPInvestment firm · $9.8 bn
- Altimeter Capital ManagementInvestment firm · $9.8 bn